David Dworaczyk, PhD: FDA Review is Anticipated for an Epinephrine Nasal Spray

Bryn Pharma is planning to submit the New Drug Application for Utuly this year and expects to receive approval early next year.

Related Keywords

David Dworaczyk , ,Bryn Pharma ,New Drug Application ,